Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer

Gynecological Endocrinology

Volumn 25, Issue 3, 2009, Pages 183-187

  Pfeiler, Georg ^a,b   Treeck, Oliver ^a   Wenzel, Gitte ^a   Goerse, Regina ^a   Hartmann, A ^c   Schmitz, Gerd ^a   Ortmann, Olaf ^a,d  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d CARITAS KRANKENHAUS ST JOSEF   (Germany)

Author keywords

Body mass index; Breast cancer; Estrogen receptor; Menopause; Steroid sulfatase

Indexed keywords

AROMATASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; STERYL SULFATASE;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER INVASION; CLINICAL ARTICLE; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH VESSEL; MENOPAUSE; METABOLISM; MICRODISSECTION; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SERUM;

ADULT; AGED; AGED, 80 AND OVER; AROMATASE; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MENOPAUSE; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; STERYL-SULFATASE;

EID: 67649541634     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802549825     Document Type: Article

References (22)

1. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335(7630):1134.
2. Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr Cancer 2003;45(1):1-16.
3. Harada N, Utsumi T, Takagi Y. Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancer. Pharmacogenetics 1995;5:S59-S64.
4. Suzuki T, Nakata T, Miki Y, Kaneko C, Moriya T, Ishida T, Akinaga S, Hirakawa H, Kimura M, Sasano H. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 2003;63(11):2762-2770.
5. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001;29(14):2905-2919.
6. Fukutomi T, Akashi-Tanaka S. Prognostic and predictive factors in the adjuvant treatment of breast cancer. Breast Cancer 2002;9(2):95-99.
7. Roger P, Sahla ME, Mäkelä S, Gustafsson JA, Baldet P, Rochefort H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 2001;61(6):2537-2541.
8. Lindberg MK, Movérare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, Ohlsson C. Estrogen receptor (ER)-beta reduces (ER)-alpha-regulated gene transcription, supporting a "ying yang" relationship between (ER)-alpha and (ER)-beta in mice. Mol Endocrinol 2003;17(2):203-208.
9. Treeck O, Pfeiler G, Horn F, Federhofer B, Houlihan H, Vollmer A, Ortmann O. Novel estrogen receptor beta transcript variants identified in human breast cancer cells affect cell growth and apoptosis of COS-1 cells. Mol Cell Endocrinol 2007;264(1-2):50-60.
10. Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue. Breast Cancer Res Treat 2006;99(3):275-288.
11. Iwao K, Miyoshi Y, Egawa C, Ikeda N, Tsukamoto F, Noguchi S. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction. Cancer 2000;89(8): 1732-1738.
12. Zaichuk T, Ivancic D, Scholtens D, Schiller C, Khan SA. Tissue-specific transcripts of human steroid sulfatase are under control of estrogen signaling pathways in breast carcinoma. J Steroid Biochem Mol Biol 2007;105(1-5):76-84.
13. Saji S, Hirose M, Toi M. Clinical significance of estrogen receptor beta in breast cancer. Cancer Chemother Pharmacol 2005;56(Suppl 1):21-26.
14. Poola I, Fuqua SA, De Witty RL, Abraham J, Marshallack JJ, Liu A. Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention. Clin Cancer Res 2005;11(20): 7579-7585.
15. Mandusić V, Nikolić-Vukosavljević D, Tanić N, Kanjer K, Neskovic-Konstantinović Z, Celeketić D, Dimitrijević B. Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer. J Cancer Res Clin Oncol 2007;133(8):571-579.
16. Ståhlberg A, Åman P, Ridell B, Mostad P, Kubista M. A quantitative real-time PCR method for detection of B-Lymphocyte monoclonality by comparison of kappa and lambda Immunoglobulin Light Chain Expression. Clin Chem 2003;49(1):51-59.
17. (-ΔΔCt) method. Methods 2001;25(4):402-408.
18. Järvinen TA, Pelto-Huikko M, Holli K, Isola J. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 2000;156(1):29-35.
19. Skliris GP, Munot K, Bell SM, Carder PJ, Lane S, Horgan K, Lansdown MR, Parkes AT, Hanby AM, Markham AF, et al. Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J Pathol 2003; 201(2):213-220.
20. Saceda M, Lippman ME, Lindsey RK, Puente M, Martin MB. Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Mol Endocrinol 1989:1782-1787.
21. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M, Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and post-menopausal breast cancer patients. J Clin Endocrinol Metab 1996;81(4):1460-1464.
22. Yamamoto Y, Yamashita J, Toi M, Muta M, Nagai S, Hanai N, Furuya A, Osawa Y, Saji S, Ogawa M. Immuno-histochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues. Oncol Rep 2003;10(4):791-796.